Fractyl Health, Inc. rose 11.3% on Friday, November 13, 2026, on 422,638 shares. Headlines around the move:
Fractyl Health, Inc. (GUTS:NASDAQ) closed at $0.904 on November 13, 2026, up 11.27% on the day. The stock trades 96.9% below its 52-week high of $29.34 and 13.0% above its 52-week low of $0.800. Over the past year, it lost 94.7%. Fractyl Health, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, GUTS closed higher on 109 days (43%). Its best day was May 13, 2026 (+29.16%) and its worst was January 29, 2026 (-68.03%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 3 times.
Fractyl Health is a leading metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Our Revita and Rejuva platform candidates are designed to target root causes of metabolic diseases and to transform metabolic disease treatment from chronic management to potentially preventing and reversing metabolic disease.
Find more stocks like GUTS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.